Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
---|---|---|---|---|---|---|
2010 | Emodin enhances cisplatin-induced cytotoxicity via down-regulation of ERCC1 and inactivation of ERK1/2 | JEN-CHUNG KO ; Su Y.-J.; Lin S.-T.; Jhan J.-Y.; Ciou S.-C.; Cheng C.-M.; Chiu Y.-F.; Kuo Y.-H.; Tsai M.-S.; Lin Y.-W. | Lung Cancer | 48 | 43 | |
2009 | Emodin enhances gefitinib-induced cytotoxicity via Rad51 downregulation and ERK1/2 inactivation | Chen R.-S.; Jhan J.-Y.; Su Y.-J.; Lee W.-T.; Cheng C.-M.; Ciou S.-C.; Lin S.-T.; Chuang S.-M.; JEN-CHUNG KO ; Lin Y.-W. | Experimental Cell Research | 28 | 26 | |
2013 | Potential therapeutic role of hispidulin in gastric cancer through induction of apoptosis via NAG-1 signaling | Yu C.Y.; KANG-YI SU ; Lee P.-L.; Jhan J.-Y.; Tsao P.-H.; Chan D.-C.; Chen Y.-L.S. | Evidence-based Complementary and Alternative Medicine | 35 | 31 | |
2009 | The role of celecoxib in Rad51 expression and cell survival affected by gefitinib in human non-small cell lung cancer cells | JEN-CHUNG KO ; Wang L.-H.; Jhan J.-Y.; Ciou S.-C.; Hong J.-H.; Lin S.-T.; Lin Y.-W. | Lung Cancer | 9 | 9 | |
2009 | Roles of MKK1/2-ERK1/2 and phosphoinositide 3-kinase-AKT signaling pathways in erlotinib-induced Rad51 suppression and cytotoxicity in human non-small cell lung cancer cells | JEN-CHUNG KO ; Ciou S.-C.; Jhan J.-Y.; Cheng C.-M.; Su Y.-J.; Chuang S.-M.; Lin S.-T.; Chang C.-C.; Lin Y.-W. | Molecular Cancer Research | 45 | 40 | |
2010 | Suppression of ERCC1 and Rad51 expression through ERK1/2 inactivation is essential in emodin-mediated cytotoxicity in human non-small cell lung cancer cells | JEN-CHUNG KO ; Su Y.-J.; Lin S.-T.; Jhan J.-Y.; Ciou S.-C.; Cheng C.-M.; Lin Y.-W. | Biochemical Pharmacology | 71 | 62 |